Skip to main content

Top navigation

  • GSA Award
  • For Veterans
  • HCP Portal
  • Pay My Bill Online
  • Contact Us
  • +1 844 396 7663
Bio-Techne Exosome logo

Main navigation

  • Physicians
    • How to Order the ExoDx™ Prostate Test
    • ExoDx™ Prostate Test: At-Home Collection Kit
    • ExoDx™ Prostate Test
    • Challenge of Prostate Cancer
    • Physician FAQs
    • What are Exosomes
    • Publications and Abstracts
    • mpMRI + ExoDx Prostate Test
  • Patients
    • The ExoDx Prostate Test
    • How to Order the ExoDx™ Prostate Test
    • Physician Finder
    • Understanding PSA Levels
    • Elevated PSA Levels
    • Normal PSA Levels & PSA Levels by Age
    • About Prostate Cancer
    • ZERO - The End of Prostate Cancer
    • Patient FAQs
    • ExoCARES Program
  • Pharma Services
    • Working with Us
    • Biomarker Discovery
    • Assay Development
    • Exosome Enrichment Capabilities
    • Companion Diagnostics (CDx) and Clinical Trial Support
  • Our Technology
    • Our Technology
    • Sensitivity to RNA/DNA
    • Extraction Procedures
    • Superiority to cfDNA and CTCs
  • News & Resources
    • Literature
    • Press
    • Webinars
    • Events
    • Newsletters

Top navigation

  • GSA Award
  • For Veterans
  • HCP Portal
  • Pay My Bill Online
  • Contact Us
  • +1 844 396 7663

News

  • “Exosome Diagnostics, Intezyne to Develop Exosomal RNA Assay for Novel CRP Inhibitor,”

    News Mar 14, 2018

    GenomeWeb
  • “Exosome Diagnostics Launches Evidence Development Study for Prostate Cancer Test,”

    News Sep 19, 2017

    GenomeWeb
  • “Private Payor, ExoDx band together for studies on diagnostic tests,”

    News Aug 28, 2017

    MedCity News
  • “Exosome Diagnostics, Private Payor partner to speed up coverage for diagnostic tests,”

    News Aug 25, 2017

    FierceBiotech
  • “New Products Posted to GenomeWeb: Exosome Diagnostics, Lexogen, Canon BioMedical, More,”

    News Aug 11, 2017

    GenomeWeb
  • “Exosome Diagnostics Launches the MedOncAlyzer™ Pan-Cancer Panel,”

    News Aug 10, 2017

    Morningtstar

(844) 396-7663
exosomedx.info@bio-techne.com
266 Second Ave, Suite 200
Waltham, MA 02451

Footer menu

  • About Bio-Techne
  • Management Team
  • Careers
  • Investors
  • Corporate Responsibility
  • Accreditation and Licensure

Social navigation

  • Facebook
  • Twitter
  • LinkedIn

The ExoDx Prostate Test was evaluated and its performance characteristics determined by Exosome Diagnostics, Inc. Exosome Diagnostics is certified under the Clinical Laboratory Improvement Amendments (CLIA) Act of 1988 as qualified to perform high complexity clinical testing. CLIA number: 22D2093470.  Exosome Diagnostics and ExoDx are registered trademarks of Exosome Diagnostics, Inc.

© 2025 ExoDx

Bottom footer navigation

  • Privacy Policy